Diaceutics Plc (DXRX) Stock Recommendation | Score, Valuation, Technicals & Financial Trend

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Diaceutics Plc

Oxford Biomedica Plc

Optibiotix Health Plc

Scancell Holdings Plc

Oxford BioDynamics Plc

Ondine Biomedical, Inc.

PureTech Health Plc

4basebio Plc

e-Therapeutics Plc

HemoGenyx Pharmaceuticals Plc

Oncimmune Holdings Plc

Why is Diaceutics Plc ?

With a growth in Net Sales of 4.29%, the company declared Very Positive results in Dec 25

ROCE(HY) Highest at 0.24%
RAW MATERIAL COST(Y) Fallen by -14.88% (YoY)
NET SALES(Q) Highest at GBP 23.87 MM

With ROE of 0.24%, it has a very attractive valuation with a 3.06 Price to Book Value

Over the past year, while the stock has generated a return of 26.50%, its profits have risen by 105.9% ; the PEG ratio of the company is 1.2

Real-Time Research Report

Verdict Report

How much should you buy?

Overall Portfolio exposure to Diaceutics Plc should be less than 10%
Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Diaceutics Plc for you?

High Risk, Medium Return

Absolute

Risk Adjusted

Volatility

Diaceutics Plc

26.5%

0.46

33.73%

FTSE 100

17.87%

1.52

11.77%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

24.79%

EBIT Growth (5y)

6.03%

EBIT to Interest (avg)

-1.06

Debt to EBITDA (avg)

Net Debt to Equity (avg)

-0.32

Sales to Capital Employed (avg)

0.60

Tax Ratio

10.74%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

0.74%

ROE (avg)

0.95%

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

124

Industry P/E

Price to Book Value

3.06

EV to EBIT

-116.91

EV to EBITDA

20.88

EV to Capital Employed

3.50

EV to Sales

3.04

PEG Ratio

1.17

Dividend Yield

ROCE (Latest)

-0.63%

ROE (Latest)

0.24%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bearish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Bullish

Moving Averages

Mildly Bullish (Daily)

KST

Mildly Bearish

Dow Theory

Mildly Bearish

OBV

No Trend

Mildly Bullish

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

16What is working for the Company

ROCE(HY)

Highest at 0.24%

RAW MATERIAL COST(Y)

Fallen by -14.88% (YoY

NET SALES(Q)

Highest at GBP 23.87 MM

OPERATING PROFIT(Q)

Highest at GBP 6.25 MM

OPERATING PROFIT MARGIN(Q)

Highest at 26.17 %

PRE-TAX PROFIT(Q)

Highest at GBP 3.29 MM

NET PROFIT(Q)

Highest at GBP 2.5 MM

EPS(Q)

Highest at GBP 0.03

-3What is not working for the Company

CASH AND EQV(HY)

Lowest at GBP 7.34 MM

DEBT-EQUITY RATIO (HY)

Highest at -15.3 %

DEBTORS TURNOVER RATIO(HY)

Lowest at 2.1 times

Here's what is working for Diaceutics Plc

Net Profit

At GBP 2.5 MM has Grown at 183.54%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very positive

Net Profit (GBP MM)

Pre-Tax Profit

At GBP 3.29 MM has Grown at 142.85%

Year on Year (YoY)

MOJO Watch

Near term Pre-Tax Profit trend is very positive

Pre-Tax Profit (GBP MM)

Net Sales

Highest at GBP 23.87 MM

in the last five periods

MOJO Watch

Near term sales trend is positive

Net Sales (GBP MM)

Operating Profit

Highest at GBP 6.25 MM

in the last five periods

MOJO Watch

Near term Operating Profit trend is positive

Operating Profit (GBP MM)

Operating Profit Margin

Highest at 26.17 %

in the last five periods

MOJO Watch

Company's profit margin has improved

Operating Profit to Sales

Pre-Tax Profit

Highest at GBP 3.29 MM

in the last five periods

MOJO Watch

Near term Pre-Tax Profit trend is positive

Pre-Tax Profit (GBP MM)

Net Profit

Highest at GBP 2.5 MM

in the last five periods

MOJO Watch

Near term Net Profit trend is positive

Net Profit (GBP MM)

EPS

Highest at GBP 0.03

in the last five periods

MOJO Watch

Increasing profitability; company has created higher earnings for shareholders

EPS (GBP)

Raw Material Cost

Fallen by -14.88% (YoY)

MOJO Watch

The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Depreciation

Highest at GBP 3.11 MM

in the last five periods

MOJO Watch

The expenditure on assets done by the company may have gone into operation

Depreciation (GBP MM)

Here's what is not working for Diaceutics Plc

Cash and Eqv

Lowest at GBP 7.34 MM

in the last six Semi-Annual periods

MOJO Watch

Short Term liquidity is deteriorating

Cash and Cash Equivalents

Debt-Equity Ratio

Highest at -15.3 %

in the last five Semi-Annual periods

MOJO Watch

The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Debtors Turnover Ratio

Lowest at 2.1 times

in the last five Semi-Annual periods

MOJO Watch

Company's pace of selling Debtors has slowed

Debtors Turnover Ratio